Investigation of interaction between salmeterol and fluticasone propionate and its effect on quantitative accuracy of an LC/MS/MS assay in human plasma at low pg/mL concentrations

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 876, Issue 2, 2008, Pages 163-169

  Carter, Spencer J ^a   Čápka, Vladimír ^a  

^a Northwest Toxicology Inc   (United States)

Author keywords

Fluticasone; Human plasma; Interaction; Liquid chromatography; Mass spectrometry; Salmeterol

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; FLOW INTERACTIONS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN); PLASMAS; THEOREM PROVING;

ADVERSE EFFECTS; ANALYTE; ANALYTES; FLUTICASONE; FLUTICASONE PROPIONATES; HUMAN PLASMA; HUMAN PLASMAS; INTERACTION; LC/MS/MS; NEGATIVE IMPACTS; PLASMA ANALYSIS; QUANTITATIVE ACCURACIES; SALMETEROL; SAMPLE PREPARATIONS;

PLASMA DIAGNOSTICS;

FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALMETEROL XINAFOATE;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; FOOD AND DRUG ADMINISTRATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

ALBUTEROL; ANDROSTADIENES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; DRUG STABILITY; HUMANS; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; SOLVENTS; TANDEM MASS SPECTROMETRY;

EID: 56549125177     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.10.034     Document Type: Article

References (20)

1. Nelson H.S. J. Allergy Med. Immunol. 107 (2001) 398
2. Barnes P.J. Eur. Respir. J. 19 (2002) 182
3. Keating G.M., and McCormack P.L. Drugs 67 (2007) 2383
4. Michael Y., Chowdhry B.Z., Ashurst I.A., Snowden M.J., Davies-Cutting C., and Gray S. Int. J. Pharm. 200 (2000) 279
5. Michael Y., Snowden M.J., Chowdhry B.Z., Ashurst I.C., Davies-Cutting C.J., and Riley T. Int. J. Pharm. 221 (2001) 165
6. Zhou T., Hu Q., Yu H., and Fang Y. Anal. Chim. Acta 441 (2001) 23
7. Kim K.H., Yun H.W., Kim H.J., Park H.J., and Choi P.W. Arch. Pharm. Res. 21 (1998) 212
8. Lehner A.F., Hughes C.G., Krapiesiuk W., Camargo F.C., Harkins J.D., Woods W.E., Bosken J., Boyles J., Troppmann A., and Tobin T. Chromatographia 59 Suppl. 1 (2004) S79
9. Van Eenloo P., Deventer K., and Delbeke F.T. Rapid Commun. Mass Spectrom. 16 (2002) 1755
10. Colthup P.V., Young G.C., and Felgate C.C. J. Pharm. Sci. 82 (1993) 323
11. Colthup P.V., and Young G.C. Methodol. Surv. Biochem. Anal. 22 (1992) 233
12. Capka V., and Carter S.J. J. Chromatogr. B 856 (2007) 285
13. Callejas S.L., Biddlecombe R.A., Jones A.E., Joyce K.B., Pereira A.I., and Pleasance S. J. Chromatogr. B 718 (1998) 243
14. Laugher L., Noctor T.G., Barrow A., Oxford J.M., and Phillips T. J. Pharm. Biomed. Anal. 21 (1999) 749
15. Krishnaswami S., Möllmann H., Derendorf H., and Hochhaus G. J. Pharm. Biomed. Anal. 22 (2000) 123
16. Deng M., Cooper A., and Thiessen J. Proceedings of the 53rd Conference of the American Society for Mass Spectrometry and Allied Topics. San Antonio, TX (2005)
17. Zhou D., Zhou G., Scotto C., Caruso J., Wu J., and Li Y. Proceedings of the 51st Conference of the American Society for Mass Spectrometry and Allied Topics. Montreal, Canada (2003)
18. Murnane D., Martin G.P., and Marriott C. J. Pharm. Biomed. Anal. 1149 (2006) 1149
19. Guidance for Industry. Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, 2001.
20. Brogden R.N., and Faulds D. Drugs 42 (1991) 895